Search

Can, Mehmet ", Ramesh S Ayyala, and Nurettin" Sahiner. 2019. “Crosslinked Poly(Lactose) Microgels and Nanogels for Biomedical Applications”. J. Colloid Interface Sci. 553: 805-12.

Suner, Selin S ", Sahin Demirci, Berkant and Yetiskin, Rawil Fakhrullin, Ekaterina Naumenko, Oguz Okay, Ramesh S Ayyala, and Nurettin " Sahiner. 2019. “Cryogel Composites Based on Hyaluronic Acid and Halloysite Nanotubes As Scaffold for Tissue Engineering”. Int. J. Biol. Macromol. 130: 627-35.

Ayyala, Ramesh S, Jessica Laursen Duarte, and . 2006. “Glaucoma Drainage Devices: State of the Art”. Expert Rev. Med. Devices 3 (4): 509-21.

Weiner, WJ, SA Factor, J Jankovic, RA Hauser, JW Tetrud, CH Waters, LM Shulman, and . 2001. “The Long-Term Safety and Efficacy of Pramipexole in Advanced Parkinson’s Disease. Parkinsonism and Related Disorders 2001;7(2)115-120.”. Parkinsonism and Related Disorders.

Hauser, RA, J Friedlander, MJ Baker, J Thomas, and R Zuckerman. 2000. “Adult Chediak-Higashi Parkinsonian Syndrome With Dystonia. Movement Disorders 2000;15:705-708.”. Movement Disorders.

Freeman, TB, RA Hauser, AE Willing, T Zigova, PR Sanberg, and S Saporta. 2000. “Transplantation of Human Fetal Striatal Tissue in Huntington’s Disease: Rationale for Clinical Studies. Novartis Foundation Symposium 2000;231:129-138; Discussion 139-147.”. Novartis Foundation Symposium.

Zesiewicz, TA, and RA Hauser. 2000. “Depression in Parkinson’s Disease. CNS Drugs 2000;17;593-600.”. CNS Drugs.

Hauser, RA, MN Wahba, TA Zesiewicz, and WM Anderson. 2000. “Modafinil Treatment of Pramipexole Associated Somnolence. Movement Disorders 2000;15:1269-1271.”. Movement Disorders.

Kordower, JH, TB Freeman, EY Chen, EJ Mufson, PR Sanberg, RA Hauser, B Snow, and CW Olanow. 1998. “Fetal Nigral Grafts Survive and Mediate Clinical Benefit in a Patient With Parkinson’s Disease. Movement Disorders 1998;13:383-393.”. Movement Disorders.

Sethi, KD, CF O’Brien, JP Hammerstad, CH Adler, TL Davis, RL Taylor, J Sanchez-Ramos, JM Bertoni, and RA Hauser. 1998. “Ropinirole for the Treatment of Early Parkinson’s Disease: A 12-Month Experience. Arch Neurol 1998;55:1211-1216.”. Arch Neurol.